ANI Pharmaceuticals, Inc. (ANIP) P/E ratio

P/E ratio today
14.5×

ANI Pharmaceuticals, Inc. (ANIP) trades at 14.5× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 23.8×. Today's figure is 39.0% below the fiscal 2025 year-end. Figures as of 19 Nov 2026, 08:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
14.5×
P/E ratio, fiscal 2025
23.8×
Highest on record
178.3×fiscal 2016
Lowest on record
21.8×fiscal 2014
Fiscal years on record
72014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ANI Pharmaceuticals, Inc. P/E ratio, in more detail

Across the 7 fiscal year-ends on record (2014–2025), the highest was 178.3× in fiscal 2016 and the lowest 21.8× in fiscal 2014. Today's P/E ratio is at or below every one of the 7 fiscal year-ends on record; their median is 34.6×.

History · 7 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

ANI Pharmaceuticals, Inc. P/E ratio, year by year

ANI Pharmaceuticals, Inc. (ANIP) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today14.5×—$71.47—
202523.8×—$78.94$3.32
2024——$55.28-$1.04
202364.9×—$55.14$0.85
2022——$40.23-$3.05
2021——$46.08-$3.40
2020——$29.04-$1.88
2019123.3× 256.2% up$61.67$0.50
201834.6×—$45.02$1.30
2017——$64.45-$0.09
2016178.3× 421.5% up$60.62$0.34
201534.2× 57.0% up$45.13$1.32
201421.8×—$56.39$2.59
2013——$20.08-$0.92
2012——$7.38-$7.62
2011——$18.00-$18.90
2010——$59.04-$25.26
2009——$52.20-$50.40

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. P/E ratio: questions and answers

What is ANI Pharmaceuticals, Inc.'s P/E ratio?

ANI Pharmaceuticals, Inc. (ANIP) trades at 14.5× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 23.8×.

Is ANI Pharmaceuticals, Inc.'s P/E ratio high or low compared with its own history?

Today's P/E ratio is at or below every one of the 7 fiscal year-ends on record; their median is 34.6×.

What are the highest and lowest P/E ratio figures on record for ANI Pharmaceuticals, Inc.?

Across the 7 fiscal year-ends on record (2014–2025), the highest was 178.3× in fiscal 2016 and the lowest 21.8× in fiscal 2014.

How is ANI Pharmaceuticals, Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For ANI Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2014 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) P/E ratio”, data as of 19 November 2026. https://funkfolio.com/stock/ANIP/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.